PharmaCyte Biotech Inc (PMCB)

[DragonBear]

We are also contemplating a reverse stock split

and a possible up-listing of our common stock to The Nasdaq Capital Market (“Nasdaq”).

Microcrap scams always contemplate uplisting, and it never occurs.

Nasdaq requires that the bid price of the common stock must have a closing bid price of at least $4.00 per share in connection with an up-listing.

They require a little more than that...


NASDAQ Capital Market requirements

PMCB ineligible under Standard 1: No earnings.

PMCB ineligible under Standard 2: No positive cash flow.

PMCB ineligible under Standard 3: Market Capitalization was not >= $850M over the previous 12 months. And again no revenue >$90M per 12 months.

PMCB ineligible under Standard 4: Current Market Cap is <$160M or approx $40.8M. A R/S does nothing to change that. One would need for Kenny to issue approx 4X the current number of shares to 8B, without the PPS going down with the massive dilution. Not happening. Not to mention there's another qualifier for Standard 4 - value of assets has to be at least $80M. Currently it's $8M.

There's a little more to it, than just R/Sing the shares up to $4 - isn't there?

Like I said, Kenny can tell SHs they are "contemplating" a R/S, and uplisting. The golden dream for all Microcrap SHs. But there's no way for PMCB to get there - another not happening.